Ignite Creation Date:
2024-07-17 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06493292
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-07-02
Brief Title:
Effectiveness of Endoluminal Treatment of Autologous Arteriovenous Endovascular Fistula Failure
Sponsor:
RenJi Hospital
Organization:
RenJi Hospital
Study Overview
Official Title:
Comparison of the Efficacy of Drug-Coated Balloons and Cutting Balloons in the Treatment of Autologous Arteriovenous Fistula Stenosis A Multi-Center Prospective Real-World Study
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study was aimed at comparing the efficacy and safety of cutting balloons versus drug-coated balloons in treating venous segment stenosis of autologous arteriovenous fistulasThis is a prospective multi-center cohort study
Detailed Description:
The study will recruit 180 patients with venous segment stenosis of autologous arteriovenous fistulas at multiple centers from June 2024 to December 2025 Patients will be divided into two cohorts based on the treatment method the Cutting Balloon group and the Drug-Coated Balloon group The primary outcomes observed will be the primary patency rates of the target lesion at 1 3 6 and 12 months post-operation re-intervention rates of the target vessel and the technical success rates and procedural success rates of the two devices along with major adverse events during the perioperative period
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None